Home › Multiple Myeloma › California › Orange
Pag-aaral pangklinika para sa Multiple Myeloma sa Orange, CA
9 pag-aaral para sa Multiple Myeloma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orange (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Nagre-recruitPhase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Nagre-recruitPhase 3
- Research Site, Orange
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Nagre-recruitPhase 3
- UC Irvine, Orange
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Nagre-recruitPhase 3
- Chao Family Comprehensive Cancer Center UCI, Orange
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 3
- University of California Irvine Medical Center, Orange
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Nagre-recruitPhase 1
- UC Irvine Health, Orange
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Nagre-recruitPhase 3
- Research Site, Orange
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Nagre-recruitPhase 2
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Nagre-recruitPhase 4
- UC Irvine Health, Orange
- UCI Health, Orange
Pag-aaral para sa Multiple Myeloma sa ibang lungsod
- New York City, NY59 pag-aaral
- Boston, MA45 pag-aaral
- Atlanta, GA42 pag-aaral
- Houston, TX39 pag-aaral
- Durham, NC36 pag-aaral
- Nashville, TN31 pag-aaral
- Denver, CO26 pag-aaral
- St. Louis, MO26 pag-aaral
- Rochester, MN25 pag-aaral
- Columbus, OH25 pag-aaral
- Chicago, IL24 pag-aaral
- Milwaukee, WI23 pag-aaral
Iba pang pag-aaral sa Orange
- Non-Small Cell Lung Cancer28 pag-aaral
- Metastatic Cancer21 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Colorectal Cancer16 pag-aaral
- Kanser (lahat ng uri)15 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Kanser sa Baga15 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)14 pag-aaral
- Melanoma14 pag-aaral
- Major Depressive Disorder13 pag-aaral
- Kanser sa Tiyan13 pag-aaral
- Kanser sa Prostate13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.